1523-5378/asset/HEL_left.gif?v=1&s=7c23d73fe9d8a8a47e244308d0ab534f0cc283bc)
1523-5378/asset/HEL_centre.gif?v=1&s=cf8bd3fffe116764922e8bfc65011baca89d1235)
1523-5378/asset/HEL_right.gif?v=1&s=991138b637eed28971d1148bdb7bde4376f5f443)
Therapy of Helicobacter pylori
Article first published online: 3 SEP 2004
DOI: 10.1111/j.1083-4389.2004.00251.x
1523-5378/asset/cover.gif?v=1&s=226fe9e3b1dfe988c79e2b689f913fe6c9551c2b "Helicobacter")
Additional Information
How to Cite
McLoughlin, R., Racz, I., Buckley, M., O'Connor, H. J. and O'Morain, C. (2004), Therapy of Helicobacter pylori. Helicobacter, 9: 42–48. doi: 10.1111/j.1083-4389.2004.00251.x
Publication History
- Issue published online: 3 SEP 2004
- Article first published online: 3 SEP 2004
- Abstract
- Article
- References
- Cited By
Keywords:
- antibiotics;
- H. pylori;
- resistance;
- review;
- treatment
ABSTRACT
This represents an overview of the main data published over the last year on the therapy of Helicobacter pylori. The problem of increasing failure of H. pylori eradication has been the main focus, with increasing resistance and poor patient compliance being the main culprits. Simple regimens are necessary to improve patient compliance. New antibiotics and novel agents are appraised with mixed results.